Browse Jaunts
Help
Social
Legal

NextGen 2024: Refractory SJIA & MAS Session Part 4

NextGen 2024: Refractory SJIA & MAS Session Part 4

@SJIA_Foundation
@SJIA_Foundation
8 Followers
2 weeks ago 74
Science #macrophageactivation #sjiafoundation #sjia #stillsdisease #curesjia

NextGen 2024: Refractory SJIA & MAS Session Part 4

@SJIA_Foundation2 weeks ago

SJIA and MAS; experience from apex tertiary care referral Institution of India Narendra Bagri …
1/23
Next Gen conference,Washington DC Division of Rheumatology, Department of Pediatrics, AIIMS, New …
2/23
Next Gen conference,Washington DC Division of Rheumatology, Department of Pediatrics, AIIMS, New …
3/23
Next Gen conference,Washington DC Division of Rheumatology, Department of Pediatrics, AIIMS, New …
4/23
Next Gen conference,Washington DC Division of Rheumatology, Department of Pediatrics, AIIMS, New …
5/23
Next Gen conference,Washington DC Division of Rheumatology, Department of Pediatrics, AIIMS, New …
6/23
Next Gen conference,Washington DC Division of Rheumatology, Department of Pediatrics, AIIMS, New …
7/23
Next Gen conference,Washington DC Division of Rheumatology, Department of Pediatrics, AIIMS, New …
8/23
Next Gen conference,Washington DC Division of Rheumatology, Department of Pediatrics, AIIMS, New …
9/23
Week 1 2 3 4 Ferritin (ng/mL) Cell counts TLC (/ mm3) Platelet count (lakhs/mm3) Tachypne…
10/23
Next Gen conference,Washington DC Division of Rheumatology, Department of Pediatrics, AIIMS, New …
11/23
Case vigette 14-yr-old girl Symptomatic since 10 years of age History of multiple blood transf…
12/23
Course Managemen t Symptomatolog y Room air Orally allowed Ceftriaxone O2 Fever Respira…
13/23
Course in HDU Managemen t Symptomatolog y HHHFNC Piperacillin tazobactam/teicoplanin/septran…
14/23
Managemen t Symptomatolog y VC SIMV Piptaz/teIcoplanin Septran Valganciclovir Lipo amphoteri…
15/23
Thoughts … •Biomarkers to differentiate infection versus MAS : IL-18 ? •PLEX in MAS
16/23
Next Gen conference,Washington DC Division of Rheumatology, Department of Pediatrics, AIIMS, New …
17/23
Next Gen conference,Washington DC Division of Rheumatology, Department of Pediatrics, AIIMS, New …
18/23
Next Gen conference,Washington DC Division of Rheumatology, Department of Pediatrics, AIIMS, New …
19/23
Next Gen conference,Washington DC Division of Rheumatology, Department of Pediatrics, AIIMS, New …
20/23
Thoughts ? • Trisomy 21 and SJIA and MAS • Etoposide • JAK -i
21/23
Next Gen conference,Washington DC Division of Rheumatology, Department of Pediatrics, AIIMS, New …
22/23
Next Gen conference,Washington DC Division of Rheumatology, Department of Pediatrics, AIIMS, New …
23/23


  • ↑ Previous
  • ↓ Next
  • f Fullscreen
  • esc Exit Fullscreen
Related Jaunts
NextGen 2024: Weaning meds when disease is controlled Session Part 2
NextGen 2024: Weaning meds when disease is controlled Session Part 2
@SJIA_Foundation
2 weeks ago •  167 views
Current treatments in macrophage activation syndrome - METAPHOR projec
Current treatments in macrophage activation syndrome - METAPHOR projec
@rashmi
2 months ago •  583 views
NextGen 2024: Refractory SJIA & MAS Session Part 6
NextGen 2024: Refractory SJIA & MAS Session Part 6
@SJIA_Foundation
2 weeks ago •  73 views
NextGen 2024: Refractory SJIA & MAS Session Part 2
NextGen 2024: Refractory SJIA & MAS Session Part 2
@SJIA_Foundation
2 weeks ago •  63 views
IL-18 testing in the diagnosis and management of Still’s disease: Game-changer or Red Herring?
IL-18 testing in the diagnosis and management of Still’s disease: Game-changer or Red Herring?
@SJIA_Foundation
2 weeks ago •  81 views
NextGen 2024: Monitoring &Treating Lung Disease in SJIA Session Part 1
NextGen 2024: Monitoring &Treating Lung Disease in SJIA Session Part 1
@SJIA_Foundation
2 weeks ago •  103 views
NextGen 2024: Unmet Needs & Clinical Trial Challenges Session Part 1
NextGen 2024: Unmet Needs & Clinical Trial Challenges Session Part 1
@SJIA_Foundation
2 weeks ago •  72 views
NextGen 2024: Genetics in SJIA Session Part 1
NextGen 2024: Genetics in SJIA Session Part 1
@SJIA_Foundation
2 weeks ago •  89 views
NextGen 2024: Refractory SJIA & MAS Session Part 8
NextGen 2024: Refractory SJIA & MAS Session Part 8
@SJIA_Foundation
2 weeks ago •  66 views
NextGen 2024: Monitoring &Treating Lung Disease in SJIA Session Part 2
NextGen 2024: Monitoring &Treating Lung Disease in SJIA Session Part 2
@SJIA_Foundation
2 weeks ago •  102 views
NextGen 2024: Refractory SJIA & MAS Session Part 1
NextGen 2024: Refractory SJIA & MAS Session Part 1
@SJIA_Foundation
2 weeks ago •  65 views
Clinical significance of serum IL-18 levels for the diagnosis and monitoring of disease activity
Clinical significance of serum IL-18 levels for the diagnosis and monitoring of disease activity
@SJIA_Foundation
2 weeks ago •  284 views
NextGen 2024: Bone Marrow Transplantation (BMT) Session Part 1
NextGen 2024: Bone Marrow Transplantation (BMT) Session Part 1
@SJIA_Foundation
2 weeks ago •  347 views
NextGen 2024: Bone Marrow Transplantation (BMT) Session Part 4
NextGen 2024: Bone Marrow Transplantation (BMT) Session Part 4
@SJIA_Foundation
2 weeks ago •  73 views
BMT in SJIA patients
BMT in SJIA patients
@lucianapapaleo
1 month ago •  135 views
More from author
NextGen 2024: Weaning meds when disease is controlled Session Part 2
NextGen 2024: Weaning meds when disease is controlled Session Part 2
@SJIA_Foundation
2 weeks ago •  167 views
NextGen 2024: Weaning meds when disease is controlled Session Part 1
NextGen 2024: Weaning meds when disease is controlled Session Part 1
@SJIA_Foundation
2 weeks ago •  101 views
NextGen 2024: Genetics in SJIA Session Part 3
NextGen 2024: Genetics in SJIA Session Part 3
@SJIA_Foundation
2 weeks ago •  408 views
NextGen 2024: Genetics in SJIA Session Part 2
NextGen 2024: Genetics in SJIA Session Part 2
@SJIA_Foundation
2 weeks ago •  90 views
NextGen 2024: Genetics in SJIA Session Part 1
NextGen 2024: Genetics in SJIA Session Part 1
@SJIA_Foundation
2 weeks ago •  89 views
NextGen 2024: Monitoring &Treating Lung Disease in SJIA Session Part 2
NextGen 2024: Monitoring &Treating Lung Disease in SJIA Session Part 2
@SJIA_Foundation
2 weeks ago •  102 views
NextGen 2024: Monitoring &Treating Lung Disease in SJIA Session Part 1
NextGen 2024: Monitoring &Treating Lung Disease in SJIA Session Part 1
@SJIA_Foundation
2 weeks ago •  103 views
NextGen 2024: Bone Marrow Transplantation (BMT) Session Part 5
NextGen 2024: Bone Marrow Transplantation (BMT) Session Part 5
@SJIA_Foundation
2 weeks ago •  70 views
NextGen 2024: Bone Marrow Transplantation (BMT) Session Part 4
NextGen 2024: Bone Marrow Transplantation (BMT) Session Part 4
@SJIA_Foundation
2 weeks ago •  73 views
NextGen 2024: Bone Marrow Transplantation (BMT) Session Part 3
NextGen 2024: Bone Marrow Transplantation (BMT) Session Part 3
@SJIA_Foundation
2 weeks ago •  79 views
NextGen 2024: Bone Marrow Transplantation (BMT) Session Part 2
NextGen 2024: Bone Marrow Transplantation (BMT) Session Part 2
@SJIA_Foundation
2 weeks ago •  77 views
NextGen 2024: Bone Marrow Transplantation (BMT) Session Part 1
NextGen 2024: Bone Marrow Transplantation (BMT) Session Part 1
@SJIA_Foundation
2 weeks ago •  347 views
NextGen 2024: Refractory SJIA & MAS Session Part 8
NextGen 2024: Refractory SJIA & MAS Session Part 8
@SJIA_Foundation
2 weeks ago •  66 views
NextGen 2024: Refractory SJIA & MAS Session Part 7
NextGen 2024: Refractory SJIA & MAS Session Part 7
@SJIA_Foundation
2 weeks ago •  52 views
NextGen 2024: Refractory SJIA & MAS Session Part 6
NextGen 2024: Refractory SJIA & MAS Session Part 6
@SJIA_Foundation
2 weeks ago •  73 views
@SJIA_Foundation

Share

NextGen 2024: Refractory SJIA & MAS Session Part 4

Embed code


Swipe LEFT
to view Related

Scroll DOWN
to read doc

This website uses cookies to improve your experience. By using this site, you consent to the use of cookies.

Login

OR

Forgot password?

Don't have an account? Sign Up